Company Overview - Zomedica Corp. is a veterinary health company focused on point-of-care diagnostic and therapeutic products for equine and companion animals [3] - The company offers a range of innovative solutions including the PulseVet® shock wave system, Assisi® Loop therapeutic devices, TRUFORMA® diagnostic platform, TRUVIEW® digital cytology system, VETGuardian® monitoring system, and VETIGEL® hemostatic gel [3] - Zomedica's total addressable market in the U.S. exceeds $2 billion [3] - The company is headquartered in Michigan and employs approximately 150 people, with manufacturing and distribution facilities in Georgia and Minnesota [3] Financial Performance - Zomedica reported an 8% revenue growth in 2024, reaching $27 million [3] - As of March 31, 2025, the company maintains a strong balance sheet with approximately $65 million in liquidity [3] Strategic Initiatives - Zomedica is advancing its product offerings through strategic acquisitions and international expansion [3] - The company aims to enhance the quality of care for pets, increase pet parent satisfaction, and improve the workflow, cash flow, and profitability of veterinary practices [3] Upcoming Events - Larry Heaton, CEO of Zomedica, will present at the OTCQB Venture Virtual Investor Conference on August 7, 2025, at 1:30 PM ET [1] - The event will allow real-time interaction with investors, and an archived webcast will be available post-event [1]